Current developments in drug testing in oral fluid

Therapeutic Drug Monitoring

Volumn 30, Issue 2, 2008, Pages 196-202

  Pil, Kristof ^a   Verstraete, Alain ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Automobile driving; High pressure liquid chromatography; Narcotics; Saliva

Indexed keywords

(11 NOR DELTA 9 TETRAHYDROCANNABINOL 9 CARBOXYLIC ACID); 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; BENZODIAZEPINE; BENZOYLECGONINE; CANNABINOID; CANNABIS; COCAINE; CODEINE; METHAMPHETAMINE; MORPHINE; MORPHINE 6 ACETATE; PHENCYCLIDINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRIVING ABILITY; DRUG CLASSIFICATION; DRUG DEPENDENCE; DRUG DETERMINATION; DRUG SCREENING; FALSE POSITIVE RESULT; HUMAN; LIQUID CHROMATOGRAPHY; PASSIVE SMOKING; POINT OF CARE TESTING; PRIORITY JOURNAL; RELIABILITY; SALIVA; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY;

AUTOMOBILE DRIVING; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, LIQUID; HUMANS; IMMUNOASSAY; MASS SCREENING; MASS SPECTROMETRY; SALIVA; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 42049097456     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318167d563     Document Type: Conference Paper

References (62)

1. Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int. 2005;150:143-150.
2. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165-173.
3. Drummer OH. Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int. 2005;150:133-142.
4. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2006;27:147-159.
5. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci. 2007;1098:51-103.
6. Samyn N, Laloup M, De Boeck G. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal Bioanal Chem. 2007;388:1437-1453.
7. Abanades S, Farre M, Segura M, et al. Disposition of gammahydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring. Ther Drug Monit. 2007;29:64-70.
8. Kauert GF, Ramaekers JG, Schneider E, et al. Pharmacokinetic properties of delta(9)-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol. 2007;31:288-293.
9. Huestis MA, Cone EJ. Relationship of Delta(9)-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol. 2004;28:394-399.
10. Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Ann N Y Acad Sci. 2007;1098:104-121.
11. Peters FT, Samyn N, Kraemer T, et al. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clin Chem. 2007;53:702-710.
12. Peters FT, Samyn N, Wahl M, et al. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. J Anal Toxicol. 2003;27:552-559.
13. Peters FT, Samyn N, Lamers CT, et al. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Clin Chem. 2005;51:1811-1822.
14. Laloup M, Fernandez MDR, Wood M, et al. Correlation of Delta 9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest. Forensic Sci Int. 2006;161:175-179.
15. Samyn N, Verstraete A, Van Haeren C, et al. Analysis of drugs of abuse in saliva. Forensic Sci Rev. 1999;11:1-19.
16. Day D, Kuntz DJ, Feldman M, et al. Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol. 2006;30:645-650.
17. Moore C, Coulter C, Rana S, et al. Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9- carboxylic acid in oral fluid specimens. J Anal Toxicol. 2006;30:409-412.
18. Quintela O, Andrenyak DM, Hoggan AM, et al. A validated method for the detection of Delta 9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta 9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol. 2007;31:157-164.
19. Moore C, Ross W, Coulter C, et al. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol. 2006;30:413-418.
20. Moore C, Rana S, Coulter C, et al. Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol. 2007;31:187-194.
21. Niedbala RS, Kardos KW, Fritch DF, et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol. 2005;29:607-615.
22. Ramaekers JG, Moeller MR, van Ruitenbeek P, et al. Cognition and motor control as a function of Delta(9)-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend. 2006;85:114-122.
23. Toennes SW, Kauert GF, Steinmeyer S, et al. Driving under the influence of drugs: evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152:149-155.
24. Cheng WC, Ng KM, Chan KK, et al. Roadside detection of impairment under the influence of ketamine: evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine. Forensic Sci Int. 2007;170:51-58.
25. Raes E, Verstraete A. Evaluation of rapid point-of-collection oral fluid testing devices. In: Verstraete A, Raes E, eds. Rosita-2 Project: Final Report. Gent: Academia Press, 2006:227-257.
26. Walsh JM, Crouch DJ, Danaceau JP, et al. Evaluation of ten oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2007;31:44-54.
27. Crouch DJ, Walsh JM, Flegel R, et al. An evaluation of selected oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2005;29:244-248.
28. Walsh JM, Flegel R, Crouch DJ, et al. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J Anal Toxicol. 2003;27:429-439.
29. Cirimele V, Villain M, Mura P, et al. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS. Forensic Sci Int. 2006;161:180-184.
30. Pehrsson A, Gunnar T, Engblom C, et al. Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int. 2008;175:140-148.
31. Kintz P, Bernhard W, Villain M, et al. Detection of cannabis use in drivers with the Drugwipe device and by GC-MS after Intercept device collection. J Anal Toxicol. 2005;29:724-727.
32. Wilson L, Jehanli A, Hand C, et al. Evaluation of a rapid oral fluid point-of-care test for MDMA. J Anal Toxicol. 2007;31:98-104.
33. Davey J, Leal N, Freeman J. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists. Drug Alcohol Rev. 2007;26:301-307.
34. Cooper G, Wilson L, Reid C, et al. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Sci Int. 2005;150:239-243.
35. Kauert GF, Iwersen-Bergmann S, Toennes SW. Assay of Delta9- tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J Anal Toxicol. 2006;30:274-277.
36. Dickson S, Park A, Nolan S, et al. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci Int. 2007;165:78-84.
37. Soares J, Vincent M, Moore C. Comment on S. Dickson, A. Park, S. Nolan et al. "the recovery of illicit drugs from oral fluid sampling devices." Forensic Science International, published on line (2006). Forensic Sci Int. 2007;169:277.
38. Moore C, Vincent M, Rana S, et al. Stability of Delta(9)- tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device. Forensic Sci Int. 2006;164:126-130.
39. Quintela O, Crouch DJ, Andrenyak DM. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device. J Anal Toxicol. 2006;30:614-616.
40. Speedy T, Baldwin D, Jowett G, et al. Development and validation of the Cozart DDS oral fluid collection device. Forensic Sci Int. 2007;170:117-120.
41. Cooper G, Wilson L, Reid C, et al. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid. Forensic Sci Int. 2005;154:240-246.
42. Cooper G, Wilson L, Reid C, et al. Validation of the Cozart (R) amphetamine microplate EIA for the analysis of amphetamines in oral fluid. Forensic Sci Int. 2006;159:104-112.
43. Scheidweiler KB, Huestis MA. Avalidated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;835:90-99.
44. Cognard E, Bouchonnet S, Staub C. Validation of a gas chromatography-ion trap tandem mass spectrometry for simultaneous analyses of cocaine and its metabolites in saliva. J Pharm Biomed Anal. 2006;41:925-934.
45. Concheiro M, de Castro A, Quintela O, et al. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing. Forensic Sci Int. 2007;170:156-162.
46. Moore C, Rana S, Coulter C. Simultaneous identification of 2-carboxytetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:459-464.
47. Gunnar T, Ariniemi K, Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J Mass Spectrom. 2005;40:739-753.
48. Teixeira H, Verstraete A, Proenca P, et al. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. Forensic Sci Int. 2007;170:148-155.
49. Allen KR, Azad R, Field HP, et al. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann Clin Biochem. 2005;42:277-284.
50. Kintz P, Villain M, Concheiro M, et al. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS. Forensic Sci Int. 2005;150:213-220.
51. Laloup M, Fernandez MDR, Wood M, et al. Quantitative analysis of Delta(9)-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2005;1082:15-24.
52. Wood M, Laloup M, Fernandez MD, et al. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int. 2005;150:227-238.
53. Oiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem. 2007;53:300-309.
54. Clarke J, Wilson JF. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci Int. 2005;150:161-164.
55. Engblom C, Gunnar T, Rantanen A, et al. Driving under the influence of drugs-amphetamine concentrations in oral fluid and whole blood samples. J Anal Toxicol. 2007;31:276-280.
56. Drummer OH. Roadside Sobriety Checkpoints and Oral Fluid Testing in Victoria. Training course lecture presented at: Robert F. Borkenstein Center for Studies of Law in Action: The Effects of Drugs on Human Performance and Behavior; April 19, 2007: Indiana University, Indiana, IL.
57. Drummer OH, Gerostamoulos D, Chu M, et al. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int. 2007;170:105-110.
58. Degenhardt L, Dillon P, Duff C, et al. Driving, drug use behaviour and risk perceptions of nightclub attendees in Victoria, Australia. Int J Drug Policy. 2006;17:41-46.
59. Bernhoft IM, Steentoft A, Johansen SS, et al. Drugs in injured drivers in Denmark. Forensic Sci Int. 2005;150:181-189.
60. Dams R, Choo RE, Lambert WE, et al. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007;87:258-267.
61. SAMHSA. Proposed guidelines for mandatory drug testing. Fed Regist. 2004;69:19673-19731.
62. Verstraete A, Puddu M. Evaluation of different road side drug tests. In: Verstraete A, ed. Rosita. Roadside Testing Assessment. Gent: Rosita Consortium, 2001:167-232.